Molten Ventures — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
IMU Biosciences uses a multi-omic platform to measure over 100 million immune data points from a single blood sample, resolving 2,500 immune cell subsets to build a large-scale immune dataset.
AI & Machine LearningBiotechHealthtechLondon, GB
Thomas Hayday PhD(Co-founder & Chief Research Officer)Adam Laing PhD(Co-founder & Chief Scientific Officer)Mario Cantero MBA(Co-founder & Chief Operating Officer)Adam Laing(Founder)inJohn Baker PhD(Chief Executive Officer)
Co-investorsExpaIQ Capital
Modo builds software that guides employees inside their existing workflows to select and use the right AI tools for specific tasks, while giving leadership data on adoption and results.
AI & Machine LearningEnterprise SoftwareFuture of WorkSaaS
Johnny Chang(Co-Founder)inAngelina You(Co-Founder)in
Co-investorsOne Way VenturesETF Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.